A systematic review of effectiveness of decision aids to assist older patients at the end of life

Magnolia Cardona-Morrell, Gustavo Benfatti-Olivato, Jesse Jansen, Robin M. Turner, Diana Fajardo-Pulido, Ken Hillman

Research output: Contribution to journalReview articleResearchpeer-review

19 Citations (Scopus)

Abstract

Objective To describe the range of decision aids (DAs) available to enable informed choice for older patients at the end of life and assess their effectiveness or acceptability. Methods Search strategy covered PubMed, Scopus, Ovid MEDLINE, EMBASE, EBM Reviews, CINAHL and PsycInfo between 1995 and 2015. The quality criteria framework endorsed by the International Patient Decision Aids Standards (IPDAS) was used to assess usefulness. Results Seventeen DA interventions for patients, their surrogates or health professionals were included. Half the DAs were designed for self-administration and few described use of facilitators for decision-making. Treatment: options and associated harms and benefits, and patient preferences were most commonly included. Patient values, treatment goals, numeric disease-specific prognostic information and financial implications of decisions were generally not covered. DAs at the end of life are generally acceptable by users, and appear to increase knowledge and reduce decisional conflict but this effectiveness is mainly based on low-level evidence. Conclusions Continuing evaluation of DAs in routine practice to support advance care planning is worth exploring further. In particular, this would be useful for conditions such as cancer, or situations such as major surgery where prognostic data is known, or in dementia where concordance on primary goals of care between surrogates and the treating team can be improved. Practice implications Given the sensitivities of end-of-life, self-administered DAs are inappropriate in this context and genuine informed decision-making cannot happen while those gaps in the instruments remain.

Original languageEnglish
Pages (from-to)425-435
Number of pages11
JournalPatient Education and Counseling
Volume100
Issue number3
DOIs
Publication statusPublished - 1 Mar 2017
Externally publishedYes

Fingerprint

Decision Support Techniques
Decision Making
Advance Care Planning
Patient Care Planning
Self Administration
Patient Preference
PubMed
MEDLINE
Dementia
Primary Health Care
Health
Therapeutics
Neoplasms

Cite this

Cardona-Morrell, Magnolia ; Benfatti-Olivato, Gustavo ; Jansen, Jesse ; Turner, Robin M. ; Fajardo-Pulido, Diana ; Hillman, Ken. / A systematic review of effectiveness of decision aids to assist older patients at the end of life. In: Patient Education and Counseling. 2017 ; Vol. 100, No. 3. pp. 425-435.
@article{eaf629a115e54f0ebed8b3640a6a444a,
title = "A systematic review of effectiveness of decision aids to assist older patients at the end of life",
abstract = "Objective To describe the range of decision aids (DAs) available to enable informed choice for older patients at the end of life and assess their effectiveness or acceptability. Methods Search strategy covered PubMed, Scopus, Ovid MEDLINE, EMBASE, EBM Reviews, CINAHL and PsycInfo between 1995 and 2015. The quality criteria framework endorsed by the International Patient Decision Aids Standards (IPDAS) was used to assess usefulness. Results Seventeen DA interventions for patients, their surrogates or health professionals were included. Half the DAs were designed for self-administration and few described use of facilitators for decision-making. Treatment: options and associated harms and benefits, and patient preferences were most commonly included. Patient values, treatment goals, numeric disease-specific prognostic information and financial implications of decisions were generally not covered. DAs at the end of life are generally acceptable by users, and appear to increase knowledge and reduce decisional conflict but this effectiveness is mainly based on low-level evidence. Conclusions Continuing evaluation of DAs in routine practice to support advance care planning is worth exploring further. In particular, this would be useful for conditions such as cancer, or situations such as major surgery where prognostic data is known, or in dementia where concordance on primary goals of care between surrogates and the treating team can be improved. Practice implications Given the sensitivities of end-of-life, self-administered DAs are inappropriate in this context and genuine informed decision-making cannot happen while those gaps in the instruments remain.",
author = "Magnolia Cardona-Morrell and Gustavo Benfatti-Olivato and Jesse Jansen and Turner, {Robin M.} and Diana Fajardo-Pulido and Ken Hillman",
year = "2017",
month = "3",
day = "1",
doi = "10.1016/j.pec.2016.10.007",
language = "English",
volume = "100",
pages = "425--435",
journal = "Patient Education and Counseling",
issn = "0738-3991",
publisher = "Elsevier",
number = "3",

}

A systematic review of effectiveness of decision aids to assist older patients at the end of life. / Cardona-Morrell, Magnolia; Benfatti-Olivato, Gustavo; Jansen, Jesse; Turner, Robin M.; Fajardo-Pulido, Diana; Hillman, Ken.

In: Patient Education and Counseling, Vol. 100, No. 3, 01.03.2017, p. 425-435.

Research output: Contribution to journalReview articleResearchpeer-review

TY - JOUR

T1 - A systematic review of effectiveness of decision aids to assist older patients at the end of life

AU - Cardona-Morrell, Magnolia

AU - Benfatti-Olivato, Gustavo

AU - Jansen, Jesse

AU - Turner, Robin M.

AU - Fajardo-Pulido, Diana

AU - Hillman, Ken

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Objective To describe the range of decision aids (DAs) available to enable informed choice for older patients at the end of life and assess their effectiveness or acceptability. Methods Search strategy covered PubMed, Scopus, Ovid MEDLINE, EMBASE, EBM Reviews, CINAHL and PsycInfo between 1995 and 2015. The quality criteria framework endorsed by the International Patient Decision Aids Standards (IPDAS) was used to assess usefulness. Results Seventeen DA interventions for patients, their surrogates or health professionals were included. Half the DAs were designed for self-administration and few described use of facilitators for decision-making. Treatment: options and associated harms and benefits, and patient preferences were most commonly included. Patient values, treatment goals, numeric disease-specific prognostic information and financial implications of decisions were generally not covered. DAs at the end of life are generally acceptable by users, and appear to increase knowledge and reduce decisional conflict but this effectiveness is mainly based on low-level evidence. Conclusions Continuing evaluation of DAs in routine practice to support advance care planning is worth exploring further. In particular, this would be useful for conditions such as cancer, or situations such as major surgery where prognostic data is known, or in dementia where concordance on primary goals of care between surrogates and the treating team can be improved. Practice implications Given the sensitivities of end-of-life, self-administered DAs are inappropriate in this context and genuine informed decision-making cannot happen while those gaps in the instruments remain.

AB - Objective To describe the range of decision aids (DAs) available to enable informed choice for older patients at the end of life and assess their effectiveness or acceptability. Methods Search strategy covered PubMed, Scopus, Ovid MEDLINE, EMBASE, EBM Reviews, CINAHL and PsycInfo between 1995 and 2015. The quality criteria framework endorsed by the International Patient Decision Aids Standards (IPDAS) was used to assess usefulness. Results Seventeen DA interventions for patients, their surrogates or health professionals were included. Half the DAs were designed for self-administration and few described use of facilitators for decision-making. Treatment: options and associated harms and benefits, and patient preferences were most commonly included. Patient values, treatment goals, numeric disease-specific prognostic information and financial implications of decisions were generally not covered. DAs at the end of life are generally acceptable by users, and appear to increase knowledge and reduce decisional conflict but this effectiveness is mainly based on low-level evidence. Conclusions Continuing evaluation of DAs in routine practice to support advance care planning is worth exploring further. In particular, this would be useful for conditions such as cancer, or situations such as major surgery where prognostic data is known, or in dementia where concordance on primary goals of care between surrogates and the treating team can be improved. Practice implications Given the sensitivities of end-of-life, self-administered DAs are inappropriate in this context and genuine informed decision-making cannot happen while those gaps in the instruments remain.

UR - http://www.scopus.com/inward/record.url?scp=85005877101&partnerID=8YFLogxK

U2 - 10.1016/j.pec.2016.10.007

DO - 10.1016/j.pec.2016.10.007

M3 - Review article

VL - 100

SP - 425

EP - 435

JO - Patient Education and Counseling

JF - Patient Education and Counseling

SN - 0738-3991

IS - 3

ER -